{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:13:20Z","timestamp":1762175600944},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,8,26]],"date-time":"2003-08-26T00:00:00Z","timestamp":1061856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/1471-2261-3-9","type":"journal-article","created":{"date-parts":[[2003,9,20]],"date-time":"2003-09-20T06:55:11Z","timestamp":1064040911000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]"],"prefix":"10.1186","volume":"3","author":[{"given":"Jonathan WF","family":"Mant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne H","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FD Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Banting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stirling","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Midlands Research Consortium of General Practice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,8,26]]},"reference":[{"key":"31_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"E Benjamin","year":"1998","unstructured":"Benjamin E, Wolf P, D'Agostino R, Silbershatz H, Kannel W, Levy D: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998, 98: 946-952.","journal-title":"Circulation"},{"key":"31_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"P Wolf","year":"1991","unstructured":"Wolf P, Abbott R, Kannel W: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991, 22: 983-988.","journal-title":"Stroke"},{"key":"31_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jnnp.53.1.16","volume":"53","author":"J Bamford","year":"1990","unstructured":"Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Study \u2013 1981\u201386. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990, 53: 16-22.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"31_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","volume":"155","author":"W Feinberg","year":"1995","unstructured":"Feinberg W, Blackshear J, Laupacis A, Kronmal R, Hart R: Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med. 1995, 155: 469-473. 10.1001\/archinte.155.5.469.","journal-title":"Arch Intern Med"},{"key":"31_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"P Wolf","year":"1987","unstructured":"Wolf P, Abbott R, Kannel W: Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987, 147: 1561-1564. 10.1001\/archinte.147.9.1561.","journal-title":"Arch Intern Med"},{"key":"31_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","volume":"348","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1996","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators: Adjusted dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III RCT. Lancet. 1996, 348: 633-638. 10.1016\/S0140-6736(96)03487-3.","journal-title":"Lancet"},{"key":"31_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","volume":"82","author":"V Pengo","year":"1998","unstructured":"Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta F: Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol. 1998, 82: 433-437. 10.1016\/S0002-9149(98)00357-9.","journal-title":"Am J Cardiol"},{"key":"31_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","volume":"158","author":"AL Gullov","year":"1998","unstructured":"Gullov AL, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, Boysen G: Fixed minidose warfarin and aspirin alone and in combination vs adjusted dose warfarin for stroke prevention in atrial fibrillation. Arch Intern Med. 1998, 158: 1513-1521. 10.1001\/archinte.158.14.1513.","journal-title":"Arch Intern Med"},{"key":"31_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","volume":"319","author":"BS Hellemons","year":"1999","unstructured":"Hellemons BS, Langenberg M, Lodder J, Vermeer F, Schouten HJ, Lemmens T, van Ree JW, Knottnerus JA: Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: RCT comparing two intensities of coumarin with aspirin. BMJ. 1999, 319: 958-964.","journal-title":"BMJ"},{"key":"31_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","unstructured":"Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials. Arch Intern Med. 1994, 154: 1449-1457. 10.1001\/archinte.154.13.1449.","journal-title":"Arch Intern Med"},{"key":"31_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.281.19.1830","volume":"281","author":"M Ezekowitz","year":"1999","unstructured":"Ezekowitz M, Levine J: Preventing stroke in patients with atrial fibrillation. JAMA. 1999, 281: 1183-1835.","journal-title":"JAMA"},{"key":"31_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"R Hart","year":"1999","unstructured":"Hart R, Benavente O, McBride R, Pearce L: Antithrombotic therapy to prevent stroke in patients with AF: a meta-analysis. Ann Intern Med. 1999, 131: 492-501.","journal-title":"Ann Intern Med"},{"key":"31_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/archinte.1997.00440320143013","volume":"157","author":"Atrial Fibrillation Investigators","year":"1997","unstructured":"Atrial Fibrillation Investigators: The efficacy of aspirin in patients with atrial fibrillation. Arch Intern Med. 1997, 157: 1237-1240. 10.1001\/archinte.157.11.1237.","journal-title":"Arch Intern Med"},{"key":"31_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","volume":"342","author":"European Atrial Fibrillation Study group (EAFT)","year":"1993","unstructured":"European Atrial Fibrillation Study group (EAFT): Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993, 342: 1255-1262. 10.1016\/0140-6736(93)92358-Z.","journal-title":"Lancet"},{"issue":"8631","key":"31_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","volume":"1","author":"P Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989, 1 (8631): 175-178. 10.1016\/S0140-6736(89)91200-2.","journal-title":"Lancet"},{"key":"31_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(94)91577-6","volume":"343","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1994","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994, 343: 687-691. 10.1016\/S0140-6736(94)91577-6.","journal-title":"Lancet"},{"key":"31_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bmj.323.7306.233","volume":"323","author":"J Mant","year":"2001","unstructured":"Mant J, Fitzmaurice D, Murray E, Lip G, Hobbs F: Inclusion criteria determine results of review. BMJ. 2001, 323: 233-34. 10.1136\/bmj.323.7306.233.","journal-title":"BMJ"},{"key":"31_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bmj.322.7282.321","volume":"322","author":"F Taylor","year":"2001","unstructured":"Taylor F, Cohen H, Ebrahim S: Systematic review of long term anticoagulation or aniplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ. 2001, 322: 321-326. 10.1136\/bmj.322.7282.321.","journal-title":"BMJ"},{"key":"31_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1378\/chest.113.4.1115","volume":"113","author":"J Marine","year":"1998","unstructured":"Marine J, Goldhaber S: Controversies surrounding long term anti-coagulation of very elderly patients in atrial fibrillation. Chest. 1998, 113: 1115-1118.","journal-title":"Chest"},{"key":"31_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","volume":"156","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1996","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators: Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med. 1996, 156: 409-416. 10.1001\/archinte.156.4.409.","journal-title":"Arch Intern Med"},{"key":"31_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/archinte.160.4.470","volume":"160","author":"G Palareti","year":"2000","unstructured":"Palareti G, Hirsh J, Legnani C, Manotti C, D'Angelo A, Pengo V, Moia M, Guazzaloca G, Musolesi S, Coccheri S: Oral anticoagulation treatment in the elderly: a nested prospective case control study. Arch Intern Med. 2000, 160: 470-478. 10.1001\/archinte.160.4.470.","journal-title":"Arch Intern Med"},{"key":"31_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S: Bleeding complications of oral anticoagulant treatment: an inception cohort, prospective collaborative study (ISCOAT). Lancet. 1996, 348: 423-428. 10.1016\/S0140-6736(96)01109-9.","journal-title":"Lancet"},{"key":"31_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","volume":"124","author":"S Fihn","year":"1996","unstructured":"Fihn S, Callahan C, Martin D, McDonnell M, Henikoff J, White R: The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med. 1996, 124: 970-979.","journal-title":"Ann Intern Med"},{"key":"31_CR24","volume-title":"London, Medical Research Council","author":"Medical Research Council","year":"1997","unstructured":"Medical Research Council: MRC Topic review \u2013 Primary Health Care. London, Medical Research Council. 1997"},{"key":"31_CR25","first-page":"153","volume":"45","author":"KG Sweeney","year":"1995","unstructured":"Sweeney KG, Gray DP, Steele R, Evans P: Use of warfarin in NRAF: a commentary from general practice. Br J Gen Prac. 1995, 45: 153-158.","journal-title":"Br J Gen Prac"},{"key":"31_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archinte.1995.00430030071008","volume":"155","author":"D McCrory","year":"1995","unstructured":"McCrory D, Matchar D, Samsa G, Sanders L, Pritchett E: Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995, 155: 277-281. 10.1001\/archinte.155.3.277.","journal-title":"Arch Intern Med"},{"key":"31_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1136\/bmj.314.7093.1529","volume":"314","author":"M Sudlow","year":"1997","unstructured":"Sudlow M, Rodgers H, Kenny R, Thomson R: Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997, 314: 1529-1530.","journal-title":"BMJ"},{"key":"31_CR28","first-page":"285","volume":"47","author":"G Lip","year":"1997","unstructured":"Lip G, Golding D, Nazir M: A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Bri J Gen Prac. 1997, 47: 285-289.","journal-title":"Bri J Gen Prac"},{"key":"31_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/hrt.79.1.50","volume":"9","author":"N Wheeldon","year":"1998","unstructured":"Wheeldon N, Tayler D: Screening for atrial fibrillation in primary care. Heart. 1998, 9: 50-55. 10.1159\/000017022.","journal-title":"Heart"},{"key":"31_CR30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(98)01401-9","volume":"352","author":"M Sudlow","year":"1998","unstructured":"Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny R: Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998, 352: 1167-1171. 10.1016\/S0140-6736(98)01401-9.","journal-title":"Lancet"},{"key":"31_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/bmj.316.7130.509","volume":"316","author":"R Thomson","year":"1998","unstructured":"Thomson R, McElroy H, Sudlow M: Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 1998, 316: 509-513.","journal-title":"BMJ"},{"key":"31_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/bmj.314.7094.1563","volume":"314","author":"T Lancaster","year":"1997","unstructured":"Lancaster T, Mant J, Singer D: Stoke prevention in atrial fibrillation. BMJ. 1997, 314: 1563-1564.","journal-title":"BMJ"},{"issue":"3","key":"31_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1046\/j.1365-2141.1998.00715.x","volume":"101","author":"Haemostasis and Thrombosis Task Force","year":"1998","unstructured":"Haemostasis and Thrombosis Task Force: Guidelines on Anticoagulation. Bri J Haematol. 1998, 101: 374-387. 10.1046\/j.1365-2141.1998.00715.x. 3","journal-title":"Bri J Haematol"},{"key":"31_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1001\/archinte.159.11.1248","volume":"159","author":"E Johnson","year":"1999","unstructured":"Johnson E, Lanes S, Wentworth C, Satterfield M, Abebe B, Dicker L: A meta-regression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med. 1999, 159: 1248-1253. 10.1001\/archinte.159.11.1248.","journal-title":"Arch Intern Med"},{"key":"31_CR35","volume-title":"London, HMSO","author":"Office of Population Censuses and Surveys","year":"1994","unstructured":"Office of Population Censuses and Surveys: Morbidity statistics from general practice 1991\/2 (MSGP4). London, HMSO. 1994"},{"key":"31_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/bmj.317.7154.327","volume":"317","author":"M Sudlow","year":"1998","unstructured":"Sudlow M, Rodgers H, Kenny R, Thomson R: Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ. 1998, 317: 327-328.","journal-title":"BMJ"},{"key":"31_CR37","first-page":"734","volume":"40","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P: Validation of a short orientation memory-concentration test of cognitive impairment. Am J Psychiatry. 1983, 40: 734-739.","journal-title":"Am J Psychiatry"},{"key":"31_CR38","volume-title":"Rotterdam, Netherlands, The EuroQol Group","author":"The EuroQol Group","year":"1996","unstructured":"The EuroQol Group: EQ-5D user guide. Rotterdam, Netherlands, The EuroQol Group. 1996"},{"key":"31_CR39","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1136\/bmj.320.7243.1197","volume":"320","author":"S Thompson","year":"2000","unstructured":"Thompson S, Barber J: How should cost data in pragmatic trials be analysed?. BMJ. 2000, 320: 1197-2000. 10.1136\/bmj.320.7243.1197.","journal-title":"BMJ"},{"key":"31_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","volume":"343","author":"MJ Langman","year":"1994","unstructured":"Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG: Risks of bleeding peptic ulcer associated with individual NSAIDs. Lancet. 1994, 343: 1075-1078. 10.1016\/S0140-6736(94)90185-6.","journal-title":"Lancet"},{"key":"31_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller S: A 12-item short-form Health survey \u2013 construction of scales and preliminary tests of reliability and validity. Med Care. 1996, 34: 220-233. 10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"key":"31_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE: \"Mini-Mental State\" A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975, 12: 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatric Res"},{"key":"31_CR43","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/01.STR.28.5.1015","volume":"28","author":"C Morocutti","year":"1997","unstructured":"Morocutti C, Amabile G, Fattaposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezarri M, Pamparana F, Cocherri S: Indobufen versus warfarin in the secondary prevention of major vascular events in non rheumatic atrial fibrillation. Stroke. 1997, 28: 1015-1021.","journal-title":"Stroke"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-3-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:22:51Z","timestamp":1726244571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-3-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-3-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2003,8,26]]},"assertion":[{"value":"10 June 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}